Modeling of the Temporal Patterns of Fluoxetine Prescriptions and Suicide Rates in the United States
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: To study the potential association of antidepressant use and suicide at a population level, we analyzed the associations between suicide rates and dispensing of the prototypic SSRI antidepressant fluoxetine in the United States during the period 1960-2002. METHODS AND FINDINGS: Sources of data included Centers of Disease Control and US Census Bureau age-adjusted suicide rates since 1960 and numbers of fluoxetine sales in the US, since its introduction in 1988. We conducted statistical analysis of age-adjusted population data and prescription numbers. Suicide rates fluctuated between 12.2 and 13.7 per 100,000 for the entire population from the early 1960s until 1988. Since then, suicide rates have gradually declined, with the lowest value of 10.4 per 100,000 in 2000. This steady decline is significantly associated with increased numbers of fluoxetine prescriptions dispensed from 2,469,000 in 1988 to 33,320,000 in 2002 (r(s) = -0.92; p < 0.001). Mathematical modeling of what suicide rates would have been during the 1988-2002 period based on pre-1988 data indicates that since the introduction of fluoxetine in 1988 through 2002 there has been a cumulative decrease in expected suicide mortality of 33,600 individuals (posterior median, 95% Bayesian credible interval 22,400-45,000). CONCLUSIONS: The introduction of SSRIs in 1988 has been temporally associated with a substantial reduction in the number of suicides. This effect may have been more apparent in the female population, whom we postulate might have particularly benefited from SSRI treatment. While these types of data cannot lead to conclusions on causality, we suggest here that in the context of untreated depression being the major cause of suicide, antidepressant treatment could have had a contributory role in the reduction of suicide rates in the period 1988-2002.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878 · cited 1×
“An interesting metaanalysis in which papers were stratified by type of presentation revealed that in patients hospitalized for suicidality the lifetime prevalence of suicide was 8.6%; for affective disorder patients hospitalized without specification of suicidality, the lifetime risk of suicide was 4.0%, and for mixed…”
BackgroundInfluentialResearch and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656
Self-citationThe Relationship Between Antidepressant Medication Use and Rate of Suicide
Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.165 · Cited by 393
Suicide, suicidality and suicide prevention in affective disorders
Möller, H. J. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.15.x · Cited by 127
Down‐rating lifetime suicide risk in major depression
Blair‐West, G. W., Mellsop, G. W., & Eyeson‐Annan, M. L. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09629.x · Cited by 108
Cited by
Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609
“Milane et al looked at fluoxetine prescribing between 1988 and 2002 and observed a decline in suicide rates since its introduction.”
BackgroundMiller, M., Azrael, D., & Barber, C. (2012) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031811-124636 · Cited by 265
Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study
Gusmão, R., Quintão, S., McDaid, D., Arensman, E., Van Audenhove, C., Coffey, C., Värnik, A., Värnik, P., Coyne, J., & Hegerl, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066455 · Cited by 136
“In line with previous work looking at temporal patterns in fluoxetine prescribing and suicide rates in the US [54], co-variance analyses were performed according to first order auto-regressive (AR) models of aggregate time-series data to adjust for serial correlation in time series for each predictor (antidepressant u…”
MethodLüscher, B., & Möhler, H. (2019) · F1000Research · doi:10.12688/f1000research.18758.1 · Cited by 105
Rockett, I. R., Hobbs, G., De Leo, D., Stack, S., Frost, J. L., Ducatman, A. M., Kapusta, N. D., & Walker, R. L. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-705 · Cited by 88
“The steady decline in the suicide rate between the late 1980 s and 2000 engendered both optimistic discussion and caution concerning attribution to prescriptive use of selective serotonin reuptake inhibitors (SSRIs) and other antidepressants [1-3].”
Metadata
- Authors
- Milane, M. S., Suchard, M. A., Wong, M.-L., & Licinio, J.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-06-13
- Volume
- 3
- Issue
- 6
- Pages
- e190
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2070491911
- Cited by
- 49
- References
- 6
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modeling of the Temporal Patterns of Fluoxetine Prescriptions and Suicide Rates in the United States. https://app.cochat.ai/papers/10.1371/journal.pmed.0030190
- The paper
- Milane, M. S., Suchard, M. A., Wong, M.-L., & Licinio, J. (2006). Modeling of the Temporal Patterns of Fluoxetine Prescriptions and Suicide Rates in the United States. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0030190
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.